Analyst at Cowen & Co. Keeps The Aurora Cannabis Inc (ACB) Buy Rating They’ve Had | Thorold News

Aurora Cannabis Inc (ACB) Rating Reaffirmed

This Morning, Cowen Co. restate their Buy rating on Aurora Cannabis Inc (ACB) shares in an analyst report issued.

The stock decreased 0.83% or $0.07 during the last trading session, reaching $8.99. About 13.02M shares traded. Aurora Cannabis Inc. (ACB) has declined 10.79% since March 14, 2018 and is downtrending. It has underperformed by 15.16% the SP500.

Analysts await Aurora Cannabis Inc. (NYSE:ACB) to report earnings on May, 14. They expect $-0.05 EPS, down 25.00 % or $0.01 from last year’s $-0.04 per share. After $-0.04 actual EPS reported by Aurora Cannabis Inc. for the previous quarter, Wall Street now forecasts 25.00 % negative EPS growth.

Aurora Cannabis Inc. produces and distributes medical cannabis products. The company has market cap of $9.05 billion. It is vertically integrated and horizontally diversified across various divisions of the cannabis value chain,

... read more at: